Once-daily treatment for canine atopic dermatitis
Delivers 6-in-1 parasite protection for cats
Valuable discounts, expert information, and tips
See how injectable medications offer value beyond the prescription
The first and only FDA-Approved veterinary antiemetic
The first long-lasting monoclonal antibody therapy for canine atopic dermatitis
Vaccination for the prevention of respiratory disease caused by BRSV
The beef industry’s No. 1 branded preconditioning program
Exclusive pricing program for Cattle producers
Outstanding protection against costly respiratory and reproductive diseases
Treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites
Innovative food safety products that help deliver a farm-to-fork solution for beef
The most comprehensive guarantee available
First and only FDA-approved antibiotic for horses that offers a full course of therapy in just two doses
Annual vaccination with CORE EQ INNOVATOR helps provide the protection your horse needs
Treats and controls encysted small strongyles, bots and roundworms. QUEST PLUS contains an additional active ingredient for efficacy against tapeworms
Patented and scientific method of determining fair service pricing to improve your clinic's profitability
Connect directly to valuable dairy management resources and experts
The most "veterinarian recommended" and "producer used" prostaglandin in the market
Delivers the peace of mind and profitability that come with no milk discard
Effective and convenient treatment for acute metritis in cattle
Working together to improve reproduction
One injection treats and controls swine respiratory disease for 7 days
Protect sows and gilts from costly breeding herd diseases — parvovirus, leptospirosis and erysipelas
The industry standard for in ovo technology.
Full automation solutions for hatchery automation
Prevention and control of necrotic enteritis, increased rate of weight gain and improved feed efficiency in poultry
for the prevention of coccidiosis in poultry
modified-live vaccine that helps poultry companies reduce their overall Salmonella load
Blood glucose monitoring system
Smart new diagnostics platform that can reinvent your in-house diagnostic routines
Detect Johne’s Disease with confidence in cattle and goat herds
Simple and effective detection of a deadly Feline Virus
Accurate, affordable and easy to use
Order Beef Genetics products online
Order Dairy Genetics products online
Delivers reliable predictions of genetic merit based on test results of core traits
Represents the latest advancement in Angus genotyping technology.
Register today to learn more
Become a more effective leader
Looking for a tailored experience?
Earn continuing education credits and stay current on industry developments with Zoetis’ convenient, on-demand learning solutions.
Veterinarians, Veterinarian Techs, Business Owners, and Farm Hands
Launch your veterinary career
Veterinarian Students and Recent Graduates
Animal health expertise and results-focused resources for high-performing teams and leaders.
Veterinarians, Dairy producers, Beef producers, Equine Specialists, Pork producers, Poultry producers, Managers, Business Owners and Staff
Home / NEWS & MEDIA / Trial Shows Treatment Convenience Most Important to Horse Owners
EXCEDE® (ceftiofur crystalline free acid) Sterile Solution provided increased treatment compliance and horse owner satisfaction when treating equine bacterial infections By Mark Crisman, DVM, MS, Dipl. ACVIM, equine technical services veterinarian, Zoetis
Veterinarians often assume horse owners will prefer the lowest-cost treatment option if it provides equivalent efficacy to a higher-priced alternative. However, this assumption leaves out two key factors: treatment compliance and client convenience.
To provide veterinarians confidence in their treatment recommendations, Zoetis examined veterinarian as well as horse owner preference and satisfaction between two efficacious treatments for equine bacterial infections.
Horse owners were given the choice of two anti-infective (AIF) treatment regimens:
1. Intramuscular (IM) injection with EXCEDE® (ceftiofur crystalline free acid) Sterile Solution administered by the veterinarian four days apart, or 2. Client administration of oral trimethoprim-sulfonamide (TMS) tablets twice daily for 10 consecutive days.
Horses were examined on Day 4 to evaluate treatment response, administer the second IM dose to horses being treated with EXCEDE and, in the case of the TMS group, to verify compliance in administering oral AIF medication. The study examined 27 veterinarians from 11 equine practices in various regions of the U.S. In total, the treatment of 137 horses was included.1
Overwhelmingly, 93.1% of horse owners selected two doses of EXCEDE over twice-daily oral TMS treatment for 10 days.1
The average treatment response scores for both AIF regimens were comparable at Days 0 and 10. However, 100% of the horses treated with EXCEDE achieved full treatment compliance compared with 75% of horses treated with oral TMS tablets.1
Notably, there was a wide variance in the veterinarian’s pre-treatment cost estimate per horse with the estimated cost of EXCEDE more than double that of TMS (Table 1). However, the pre-treatment estimate differed markedly from the actual costs incurred. In the average actual cost, treatment with EXCEDE was just $20.80 greater than the TMS treatment.1
In a post-treatment survey, convenience was judged more important than price in the horse owner’s perception of value, with mean scores of 4.3 versus 3.5, respectively. The item with the greatest score differential was convenience, where EXCEDE had a near-perfect average score of 4.8 versus 3.0 for TMS. Overall client satisfaction when EXCEDE was selected had a mean score of 4.7, approaching the maximum possible score of 5.0 (Figure 1).1
The trial proved horse owners overwhelmingly prefer the most convenient therapeutic option despite higher cost. To learn more about the study or the benefits of EXCEDE, talk with your Zoetis representative or visit www.EXCEDE.com.
IMPORTANT SAFETY INFORMATIONPeople with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCEDE. EXCEDE is contraindicated in animals with known allergy to ceftiofur or to the β-lactam group (penicillins and cephalosporins) of antimicrobials. Do not use in horses intended for human consumption. The administration of antimicrobials in horses under conditions of stress may be associated with diarrhea, which may require appropriate veterinary therapy. See full Prescribing Information.
About Zoetis Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2016, the company generated annual revenue of $4.9 billion with approximately 9,000 employees. For more information, visit www.zoetisUS.com.
For more information, contact:Jaci Boggs, DVM, MS, Dipl. ACVIM Zoetis firstname.lastname@example.org
Kassi HoxmeierBader Rutterkhoxmeier@bader-rutter.com262-938-5522
Reference:1 Data on file, Study Report No. 14EQRGAIF02, Zoetis Inc.
Mon–Fri, 8am–8pm ET
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
This site is intended for U.S. Animal Healthcare Professionals.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2017 Zoetis Services LLC. All rights reserved.